Movement Alert｜XtalPi Holdings Rises 5.35% in Regular Trading, Equity Incentive Grant and Multiple Catalysts Drive Momentum

Market Focus

Jul 03

On July 3, XtalPi Holdings rose 5.35% in regular trading, trading at HKD 7.86/share, with turnover of HKD 356 million.

On the news front, the company granted approximately 34.98 million share options and 8.68 million restricted share units on July 2 at an exercise price of HKD 7.48, signaling management confidence. This adds to a series of recent positive developments: a strategic AI drug discovery partnership with an international pharmaceutical company valued at over $400 million targeting GPCR oral small-molecule therapies, a $100 million share buyback plan in continuous execution since June 10, and the successful deployment of an AI autonomous experiment workstation at Sinopec marking substantive expansion into materials science.

The broader CXO sector continued its recovery, with Wuxi XDC up 6.21%, Wuxi Biologics up 4.74%, GenScript Biotech up 3.73%, and Wuxi AppTec up 2.68%, providing sector-level tailwinds to the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1186449637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186449637\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186449637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 14:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186449637","market":"hk","top_or_hot":-1,"title":"Movement Alert｜XtalPi Holdings Rises 5.35% in Regular Trading, Equity Incentive Grant and Multiple Catalysts Drive Momentum","media":"Market Focus","content":"<p><p>On July 3, XtalPi Holdings rose 5.35% in regular trading, trading at HKD 7.86/share, with turnover of HKD 356 million.</p><p>On the news front, the company granted approximately 34.98 million share options and 8.68 million restricted share units on July 2 at an exercise price of HKD 7.48, signaling management confidence. This adds to a series of recent positive developments: a strategic AI drug discovery partnership with an international pharmaceutical company valued at over $400 million targeting GPCR oral small-molecule therapies, a $100 million share buyback plan in continuous execution since June 10, and the successful deployment of an AI autonomous experiment workstation at Sinopec marking substantive expansion into materials science.</p><p>The broader CXO sector continued its recovery, with Wuxi XDC up 6.21%, Wuxi Biologics up 4.74%, GenScript Biotech up 3.73%, and Wuxi AppTec up 2.68%, providing sector-level tailwinds to the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜XtalPi Holdings Rises 5.35% in Regular Trading, Equity Incentive Grant and Multiple Catalysts Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜XtalPi Holdings Rises 5.35% in Regular Trading, Equity Incentive Grant and Multiple Catalysts Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-03 14:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 3, XtalPi Holdings rose 5.35% in regular trading, trading at HKD 7.86/share, with turnover of HKD 356 million.</p><p>On the news front, the company granted approximately 34.98 million share options and 8.68 million restricted share units on July 2 at an exercise price of HKD 7.48, signaling management confidence. This adds to a series of recent positive developments: a strategic AI drug discovery partnership with an international pharmaceutical company valued at over $400 million targeting GPCR oral small-molecule therapies, a $100 million share buyback plan in continuous execution since June 10, and the successful deployment of an AI autonomous experiment workstation at Sinopec marking substantive expansion into materials science.</p><p>The broader CXO sector continued its recovery, with Wuxi XDC up 6.21%, Wuxi Biologics up 4.74%, GenScript Biotech up 3.73%, and Wuxi AppTec up 2.68%, providing sector-level tailwinds to the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1186449637","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186449637","pubTimestamp":1783059841,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 3, XtalPi Holdings rose 5.35% in regular trading, trading at HKD 7.86/share, with turnover of HKD 356 million.On the news front, the company granted approximately 34.98 million share options...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"异动快讯|XtalPi Holdings常规交易涨5.35%股权激励授予多重催化剂推动动能","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"On July 3, XtalPi Holdings rose 5.35% in regular trading, trading at HKD 7.86/share, with turnover of HKD 356 million.On the news front, the company granted approximately 34.98 million share options and 8.68 million restricted share units on July 2 at an exercise price of HKD 7.48, signaling management confidence. This adds to a series of recent positive developments: a strategic AI drug discovery partnership with an international pharmaceutical company valued at over $400 million targeting GPCR oral small-molecule therapies, a $100 million share buyback plan in continuous execution since June 10, and the successful deployment of an AI autonomous experiment workstation at Sinopec marking substantive expansion into materials science.The broader CXO sector continued its recovery, with Wuxi XDC up 6.21%, Wuxi Biologics up 4.74%, GenScript Biotech up 3.73%, and Wuxi AppTec up 2.68%, providing sector-level tailwinds to the stock.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}